Orphazyme Extends Use of Montrium‘s Connect Platform
Montrium has announced that Orphazyme, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, has chosen to extend Montrium’s eTMF Connect and RegDocs Connect solutions with Quality Connect to empower end-to-end commercialization processes.
With a growing team and potential for several registration studies occurring in the near-future, managing critical regulated content is a key priority for Orphazyme’s clinical teams. After determining a cloud-based system would bring unique benefits, Orphazyme’s team completed a thorough assessment of solutions on the market and selected Montrium as their strategic partner.
Montrium’s eTMF Connect application is a modern electronic Trial Master File solution that has been designed specifically for life sciences organizations to manage their clinical trial documentation. Seamlessly connected with eTMF Connect, RegDocs Connect is a regulatory submissions management tool.
In addition to the eTMF Connect & Reg Docs Connect applications, Orphazyme has also decided to expand its partnership with Montrium by selecting Quality Connect, an electronic quality management system. By leveraging Montrium’s Connect platform, Orphazyme has unified clinical, regulatory and quality activities in the cloud to modernize their core business processes.
Paul Fenton, Montrium’s Chief Executive Officer, shares, “When sponsors bring on a new software vendor like Montrium, it’s as if they bring on an extension to their team. We’re incredibly excited about partnering with such a well-established organization like Orphazyme to help them achieve their commercial goals as well as building on an existing community of Montrium customers in the Scandinavian region.”
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
